JP2018506538A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506538A5
JP2018506538A5 JP2017541999A JP2017541999A JP2018506538A5 JP 2018506538 A5 JP2018506538 A5 JP 2018506538A5 JP 2017541999 A JP2017541999 A JP 2017541999A JP 2017541999 A JP2017541999 A JP 2017541999A JP 2018506538 A5 JP2018506538 A5 JP 2018506538A5
Authority
JP
Japan
Prior art keywords
mycobacterium
appendix
pharmaceutically acceptable
infection
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017541999A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018506538A (ja
JP6771472B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/050775 external-priority patent/WO2016128948A1/en
Publication of JP2018506538A publication Critical patent/JP2018506538A/ja
Publication of JP2018506538A5 publication Critical patent/JP2018506538A5/ja
Application granted granted Critical
Publication of JP6771472B2 publication Critical patent/JP6771472B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017541999A 2015-02-12 2016-02-12 4−置換ベンゾオキサボロール化合物及びその使用 Active JP6771472B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP15382055.0 2015-02-12
EP15382054 2015-02-12
EP15382054.3 2015-02-12
EP15382055 2015-02-12
EP15382056.8 2015-02-12
EP15382056 2015-02-12
PCT/IB2016/050775 WO2016128948A1 (en) 2015-02-12 2016-02-12 4 -substituted benzoxaborole compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2018506538A JP2018506538A (ja) 2018-03-08
JP2018506538A5 true JP2018506538A5 (https=) 2019-03-14
JP6771472B2 JP6771472B2 (ja) 2020-10-21

Family

ID=55409879

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017542053A Pending JP2018506540A (ja) 2015-02-12 2016-02-12 ベンゾオキサボロール化合物及びその使用
JP2017541999A Active JP6771472B2 (ja) 2015-02-12 2016-02-12 4−置換ベンゾオキサボロール化合物及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017542053A Pending JP2018506540A (ja) 2015-02-12 2016-02-12 ベンゾオキサボロール化合物及びその使用

Country Status (36)

Country Link
US (3) US10774096B2 (https=)
EP (2) EP3256479B1 (https=)
JP (2) JP2018506540A (https=)
KR (2) KR20170117158A (https=)
CN (2) CN107548398A (https=)
AU (3) AU2016217508A1 (https=)
BR (2) BR112017017213A2 (https=)
CA (2) CA2976308A1 (https=)
CL (2) CL2017002059A1 (https=)
CO (2) CO2017008809A2 (https=)
CR (2) CR20170371A (https=)
CY (1) CY1123687T1 (https=)
DK (1) DK3256479T3 (https=)
DO (2) DOP2017000188A (https=)
EA (2) EA036516B1 (https=)
ES (1) ES2821951T3 (https=)
HR (1) HRP20201597T1 (https=)
HU (1) HUE051113T2 (https=)
IL (2) IL253865A0 (https=)
LT (1) LT3256479T (https=)
MA (2) MA41494B1 (https=)
MX (2) MX379057B (https=)
MY (1) MY194004A (https=)
NZ (1) NZ734379A (https=)
PE (2) PE20171432A1 (https=)
PH (2) PH12017501427A1 (https=)
PL (1) PL3256479T3 (https=)
PT (1) PT3256479T (https=)
RS (1) RS60885B1 (https=)
SG (2) SG11201706510YA (https=)
SI (1) SI3256479T1 (https=)
SM (1) SMT202000565T1 (https=)
TW (2) TW201702250A (https=)
UA (1) UA120527C2 (https=)
WO (2) WO2016128949A1 (https=)
ZA (1) ZA201705456B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160251380A1 (en) * 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
RS63461B1 (sr) 2017-05-08 2022-08-31 Glaxosmithkline Ip Dev Ltd Sanfetrinem ili njegova so ili estar za upotrebu u lečenju mikobakterijske infekcije
MX2020005464A (es) 2017-11-30 2020-12-03 Boragen Inc Compuestos de benzoxaborol y formulaciones de los mismos.
WO2020041200A1 (en) 2018-08-18 2020-02-27 Boragen Inc. Solid forms of substituted benzoxaborole and compositions thereof
CN110441344B (zh) * 2019-06-25 2020-09-29 北京大学 一种基于固体核磁共振技术检测rna结构的方法
EP4384527A4 (en) * 2022-06-23 2025-09-03 Micurx Pharmaceuticals Inc PRODRUGS OF BORON COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
CA3239096A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
KR20240150582A (ko) 2023-04-08 2024-10-15 김태서 맥세이프 배터리팩을 포함한 아이폰 케이스

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411587D0 (en) * 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
EP0947498B1 (en) 1996-12-02 2004-09-15 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
US7446236B2 (en) 2002-12-02 2008-11-04 Solvias Ag Catalytic hydrogenation of carbon-heteroatom double bonds
EP2343304B1 (en) 2005-02-16 2015-06-10 Anacor Pharmaceuticals, Inc. Biocidal boronophthalide compounds
EP1856113B1 (en) 2005-03-08 2016-01-06 Agency for Science, Technology and Research Chiral bisoxazoline catalysts
KR20080110984A (ko) 2005-12-30 2008-12-22 아나코르 파마슈티칼스 인코포레이티드 보론함유 소분자
TWM325238U (en) * 2006-12-29 2008-01-11 Universal Scient Ind Co Ltd Voltage regulator and voltage regulating system
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
WO2010080558A1 (en) 2008-12-17 2010-07-15 Anacor Pharmaceuticals, Inc. Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
ES2710105T3 (es) * 2010-04-07 2019-04-23 Glaxosmithkline Llc Proceso para preparar benzoxaboroles
SI3251678T1 (sl) * 2010-09-07 2022-01-31 Anacor Pharmaceuticals, Inc. Derivati benzoksaborola za zdravljenje bakterijskih okužb
JP6031122B2 (ja) * 2011-12-22 2016-11-24 ミクウルク ファーマシューティカルズ,インコーポレイテッド 抗微生物療法のための三環式ホウ素化合物
CN102739587B (zh) 2012-06-16 2014-05-21 天地融科技股份有限公司 音频数据传输方法
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
US20160251380A1 (en) 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2018506538A5 (https=)
JP2016527321A5 (https=)
NZ716350A (en) Tricyclic benzoxaborole compounds and uses thereof
ES2821951T3 (es) Compuestos de benzoxaborol sustituidos en posición 4 y sus usos
US11254689B2 (en) Compounds
CN108883114B (zh) 抗结核药物
JP2020519592A (ja) マイコバクテリア感染の処置において使用するためのサンフェトリネム、その塩、またはそのエステル
JP2020519592A5 (https=)
BR112020003192B1 (pt) Compostos da fórmula (i), uso dos ditos compostos para o tratamento de infecção micobacteriana ou de doença causada pela mesma, composição farmacêutica e combinação que compreende os compostos